BMP6 and cerebral cavernous malformation: As BMP6 upregulation has also been shown to mediate onset and progression of cerebral cavernous malformations by inducing BMP and TGFβ-signaling [11], Hippo pathway inhibitors may act as potential molecular targets for this disease.